Clinical Trial Update: Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients [NA]

View source ↗

Summary

This trial evaluated the effectiveness and safety of GB20 acupoint pharmacopuncture with lidocaine 2% in migraine patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Lidocaine 2% pharmacopuncture at GB20 (lidocaine)

Snippet

Sponsor: Indonesia University | Conditions: Migraine | NA | Status: COMPLETED